One of the methods that have been widely used in the diagnosis of urogenital chlamydia is an enzyme-
U rogenital chlamydia is one of the most common sexually transmitted infections. According to the World Health Organization, Chlamydia trachomatis infects about 90 million people each year by sexual transmission. In Ukraine, the rate of chlamydial urogenital infection is 80 cases per 100,000 population. Nearly 16% of pregnant women are infected with C. trachomatis. About 50-60% of tubular infertility cases are caused by chlamydial infection. A quarter of all ophthalmic and respiratory diseases in newborn and younger children are associated with chlamydial infection [1, 2] . The major outer membrane protein (MOMP) plays the most important role for a serological diagnostic purpose among all C. trachomatis antigens. This pathogen protein is considered the primary site for interaction with T cells, specific depending on the serovar of microorganisms. MOMP is a transmembrane porin, parts of which are localized on the surface of the pathogen cell [1, 2] Effective diagnosis is one of important components of urogenital chlamydia control. One of the commonly used methods in diagnostics is enzymelinked immunosorbent assay (ELISA) that allows doi: https://doi.org/10.15407/ubj91.03.090 differential diagnosis -determination of disease stage and course, which is especially important in chronic conditions. For that purpose, blood serum (plasma) and human biological fluids are tested for the presence of IgM, IgA and IgG classes of specific antibodies to pathogen's antigens [3, 4] .
As usual ELISA kits for the detection of specific IgM and IgA antibodies to C. trachomatis in human serum (plasma) based on the principle of indirect modification. Obtaining positive controls (PCs) is a significant problem in the production of diagnostic kits intended for the detection of IgA and IgM specific antibodies against different pathogens. The classic version of PC is the serum (plasma) of human blood containing specific antibodies of a certain class. However, the frequency of detection of IgA-and IgM-positive sera is negligible. Extremely scarce is the relevant biological material as a raw material for PC obtaining. This circumstance can significantly limit the production of diagnostic kits, especially in the context of large-scale production. In order to increase the efficiency of ELISA test kits production, we proposed a methodological approach that addresses the use of synthetic PCs: for the ELISA test kit for the diagnosis of urogenital chlamydia, based on the principle of indirect ELISA, -the use of a conjugate of IgM (IgA) normal immunoglobulins and monoclonal antibodies (McAbs) to C. trachomatis major outer membrane protein (MOMP) [4] .
The aim of this work was to obtain high active and affinity McAbs to the C. trachomatis MOMP as well as the study of its immunobiological properties which are important for future biochemical approaches.
materials and methods
Immunization of animals. An immunization schema for Вalb/с mice was chosen according to available literature data and own experience [4] [5] [6] [7] [8] [9] . The most effective immune response is usually developed following immunization by antigen mixed with Freund's complete adjuvant (FCA) into hind leg pads. The antigen -recombinant protein, a complete homologue of region 191-354 a.r. (W4-W5) of the C. trachomatis main outer membrane protein (MOMP) (Virogen, USA) (the protein is synthesized in e. coli, at the C-terminus the protein contains the His 6 fragment). Immunization of the Balb/c mice was carried out subcutaneous in the hind leg pads of mice in a total dose of 70-80 μg per animal. The first two injections were made with Freund's complete adjuvant (FCA), and the third one -without adjuvant. The first three injections lasted for a week. Three months after the start of immunization, an intravenous booster dose of antigen (70-80 μg) was injected intravenously, and on the third day, hybridization of the splenocytes from the mouse spleen with the myeloma cells Sp 2/0 was performed. Thus, the total dose of antigen was 140-160 μg per animal.
Obtaining of hybridomas. The fusion was made using polyethylene glycol 3500-3700 (Sіgma, USA) according to Kohler's & Mіlsteіn's approach [10] modified by Lane & Koprowski [11] . The hybridoma clones obtained were multiplied on peritoneal macrophage feeder cells in a complete growth H-Y medium (Sіgma, USA) supplemented with calf embryo serum (Sіgma, USA) and НАТ medium (Sіgma, USA). The cells were cultivated in 96-well plates for tissue cultures (Costar, USA).
The presence of McAbs in hybridoma growth media was controlled by an indirect ELISA approach on the 10 th -12 th day of cultivation. Following experiment, the optical density values of supernatant fluids of McAbs-positive cultures were by 2-3 times higher compared to the conjugate. Cells from appropriate wells were taken into 24-well plates with peritoneal macrophage feeder cells in the complete growth medium supplemented with the HT medium (Sіgma, USA). The cells obtained were frozen in a medium containing newborn calf serum (50%, Sіgma, USA), DМЕМ medium (43%, Sіgma, USA), and dimethylsulfoxide (7%, Sіgma, USA). The aliquots of culture fluids were used to determine the McAbs specificity, their titers and affinity constants as well as their isotypes. The McAbs specificity was evaluated by an indirect ELISA approach with recombinant antigen. The hybridomas secreting the most active McAbs of the highest affinity having demonstrated positive results were taken for the next work. The chosen hybridoma clones were then thawed and cloned several times to reach stable levels of antibody synthesis. The cloning was carried out using the end-point dilution method; the hybridoma cells were grown on peritoneal macrophage feeder cells in the complete growth medium.
Hybridoma cells with stabile antibody production were multiplied and injected to mice in order to obtain ascite fluids, the mice having been previously primed by pristane (Sіgma, USA). The MAb purification from ascite fluids was carried out by a double precipitation protocol using 18% and 16% Na 2 SO 4 (w/v) [7] . The McAb preparations obtained in such way were taken for the synthesis of horse-radish peroxidase (HRP) containing conjugates.
Indirect elISa. The sorption of MOMP was made overnight in 0.05 M carbonate-bicarbonate buffer (рН 9.6) at 4 °С, their concentrations being 2.5 mg/ml. For plate washing, a phosphate salt buffer supplemented with the Tween 20 (0.05%) (PBS-T, рН 7.2) was used. The plates were incubated with hybridoma culture medium during 1 h (37 °C) and then washed. To detect the bound antibodies, goat HRP-conjugated anti-mouse immunoglobulins were taken. Immunoenzyme conjugate was added to the wells, incubated during 1 h at the ambient temperature and washed away (three times by the PBS-T and once by water). In all experiments, 0.003 % hydrogen peroxide in 0.15 М citrate buffer (pH 5.0) was used as a substrate, and 3,3′,5,5′-tetramethylbenzidine was a chromogen. The reaction was stopped by 2 M sulphuric acid. The optical density values were read at wavelengths 450/620 nm by a spectrophotometer.
Evaluation of McAbs affinity. The McAb affinity constants were evaluated according to the inhibition method proposed by B. Friguet [12] , modified by B. Kim [13] . Affinity constants were calculated by S. Bobrovnik recommendation [14] . Immunoglobulin solutions with different MOMP concentrations (10-9-10-6 mole per litter) were mixed with McAbscontaining culture fluid samples. Following incubation (1 hour at 37 °С) the mixtures were put into 96-well plate wells sensitized previously by MOMP preparation and the ELISA performance was carried out. Control plate wells contained culture fluid samples non-incubated with the MOMP preparation.
Determination of Mcabs isotype. The isotype determination of the McAbs obtained was made using a standard kit for this procedure -ISO-2 (Sіgma, USA). The isotyping was carried out by antigen-mediated ELISA. Hybridoma culture fluids were put into the plate wells sensitized by MOMP, each sample was put into six wells. The McAbs isotype was determined by a monospecific goat serum. The typing antibodies were detected by an anti-goat HRP-containing conjugate (Sіgma, USA). The results were read according to the manufacturer's reco mmendations.
epitope mapping. The procedure was based on the algorithm described by Rechkina et al. [15] . The following modification of the ELISA method was used to evaluate the specificity of binding of phages with McAbs to MOMP. McAbs were sorted by 96-well plates at a concentration of 2 μg/ml for 12 h at 4 °C (carbonate buffer solution, pH 8.6, was used for immobilization). After incubation with the blocking buffer to reduce the possible nonspecific binding and 6-fold washings, PBS-T (рН 7.2), was applied to the wells by phage clones at a concentration of 10 10 plaque-forming unit (PFU) per ml, incubated for 1 h at room temperature. After washing in a hole, conjugated horseradish peroxidase was introduced to polyclonal antibodies against bacteriophage M13 pIII. The next procedure was carried out similarly to the indirect ELISA protocol.
Bioethical norms. The research was conducted in accordance with international and national bioethi cal recommendations.
results and discussion
As previously noted immunization of the Balb/c mice was carried out with recombinant protein -a complete homologue of the 191-354 a.r. (W4-W5) of the C. trachomatis main outer membrane protein. As a result of hybridization of mouse splenocytes about 400 clones were obtained. In the initial testing after hybridization, the specific antibodies to the MOMP were detected in all wells of seven tablets. Cultural fluids during the screening were diluted several times, which allowed to significantly reducing the background signal. Thus, 18 clones that had the highest signals according to the results of indirect ELISA were selected. All selected hybridomas were cryopreserved, and culture fluids were left for further study. After repeated testing in ELISA, high activity of the McAbs was confirmed in 16 clones (Table) .
At the next stage of the work, in-depth study of the properties of the McAbs was carried out on the following characteristics: the titer of antibodies in the culture liquid, affinity and their isotype. Characteristics of the McAbs for the first two criteria (titer and affinity) would enable to assess the prospects of the use of such McAbs in the immunoassay. The isotype of antibodies, on the one hand, affects the feasibility of using McAbs in various bioanalytical methods, and, on the other hand, is an important prerequisite for choosing of McAbs isolation and purification methods.
The results of determination of the isotype of 16 obtained McAbs are presented in Table. The titer in the culture fluid, as well as the affinity constant, were determined for all McAbs, with the exception of those having IgM isotype (294G2, 296H9), due to adverse conditions of purification and possible cross-activity. More than half of the tested McAbs (8 out of 14) were characterized by a rather high titer (≥1:800), and three of them (291F8, 293F4, 296G2) had a titer of ≥1:1600. It should be noted that in general, the McAbs titer was correlated with the value of the affinity constant: McAbs with higher titles were characterized by a high value of the affinity constant. 
Notes. 1) The mean values of the values based on the results of the study of supernatants with a hybrid in 4 replicates are given (P < 0.05).
2) "+" McAbs compete with PcAbs; "-" McAbs' competition with PcAbs was not found. 3) Parameter not defined.
formed by limiting dilutions technique. All clones were cloned 1 to 3 times -up to almost complete stability at the level of synthesis of specific McAbs. Isolated positive clones from a 96-well plate were transplanted into 24-well, hybridomas were grown, frozen and administered to the mice intraperitoneally. At 7-10 days the animals accumulated ascites, which were taken. One mouse gave up to 10 ml of ascitic fluid on average. After isolation from ascitic fluid, McAbs was used for the synthesis of peroxidase conjugates that were needed to establish their epitope specificity.
In order to establish the epitope specificity of McAbs, we can use different methodological approaches. One of them is a comparative epitope speci ficity technique. We have used such approach many times [4, 5, 16] when different bioanalytical methods were developed (ELISA for determination of human IgE, IgM, and IgA). In these cases, absolute epitopic specificity is not important; for the develop ment of the analytical methods, it was important to understand the ratio of the specificity of various antibodies. Another principle is addressed to determine an antibody specific binding place (amino acid sequence) on an antigen surface (epitope) [14, 16] . When we are talking about anti-MOMP antibodies, it is necessary to understand its future application. Obtained McAbs are intended for the synthesis of synthetic (hybrid) positive controls of ELISA kits for diagnosing urogenital chlamydia. In this case, anti-MOMP monoclonal antibodies (in a conjugate with normal human immunoglobulins) should effectively interact with an antigen sorbed on a solid phase (immunosorbent). At the same time, during ELISA staging immobilized antigen interacts with specific anti-C. trachomatis polyclonal antibo dies (PcAbs) of human blood serum. Due to this circumstance, it will be expedient to analyze the molecu lar-cellular localization of the MOMP in the outer membrane of the pathogen of urogenital chlamydia and the potential orientation of the anti-MOMP immune response of the macroorganism. Based on the schematic representation of the MOMP polypeptide chain of C. trachomatis serovar F (Fig. 1) [17] , it is understandable that only certain [17] part of the polypeptide chain (the part that is located above the membrane) is avai lable for protective polyclonal antibo dies present in blood serum of infected individuals.
Fig. 1. Schematic representation of the placement of the C. trachomatis MOMP polypeptide chain serovar F in the outer membrane (the letters indicate the amino acid residues; the hinges are indicated (l); the place of formation of disulfide bonds is indicated by dotted lines)
However, one cannot reject the probability of presence in human blood serum of the PcAbs, which recognizes other ("internal") antigenic determinants of the MOMP molecule. Such antibodies probably do not have to be protective, highly affiliated and the main content of the whole repertoire of PcAbs. Thus, in this case, the localization of the antigenic determinant to which the monoclonal antibody is directed (the outer part of the MOMP polypeptide chain, a part in the transmembrane space or in the periplasm) may be important.
To evaluate the spatial localization of antigenic determinants to which the McAbs were directed, we have used competitive ELISA with PcAbs that are specific to the C. trachomatis MOMP. To implement this approach, it was necessary previously to select specific anti-MOMP polyclonal antibodies from blood serum from C. trachomatis infected individuals. For the solution of this problem at the preliminary stage of work a pool of specific PcAbs was obtained, which was used to formulate a competi- (Table) . Thus, among the received McAbs panel it was presented antibodies of both possible groups of specificity: directed toward the external epitopes of the C. trachomatis MOMP and formed by amino acid residues (a.r.) localized in the periplasmic and/or transmembrane space. Among the most active and highly affiliated McAbs were clones of both variants of epitope specificity. For a more in-depth characterization of those McAbs (291F8, 293F4, 296G2), an additional series of work was carried out to determine their absolute epitope specificity with the use of phage display technology.
As already have noted, the technology of the phage display implies the use of filamentous phages, on the surface of which whimsical proteins containing amino acid sequences as potential antigenic determinants are expressed [16] . Within the framework of this block of research, by the results of DNA sequencing we have determined the amino acid sequence of the peptide phage insert, denoting a.r. by means one-letter code.
To find the motifs, which are homological to phage peptide, a comparative analysis of the amino acid sequences of the peptide inserts and the C. trachomatis MOMP (Protein Database, NCBI) has been done. It should be noted that in the analysis, analogous as well as homologous a.r. were conside red (they were grouped according to their physical and chemical properties [15, [18] [19] [20] ), namely:
• [18, 19] , the participation of hydrophobic nonpolar a.r. in the formation of antigenic determinants of the core protein of the hepatitis C virus [20] .
It should be noted that the immunogen used in our work to produce anti-MOMP McAbs was a recombinant protein -a complete homologue of 191-354 a.r. (W4-W5) of native protein. The choice of this recombinant protein for immunization of animals was due to the results of the analysis of literature data on the study of the humoral immune response against C. trachomatis MOMP: various authors report that the site 191-354 a.r. is the most immunogenic and provides the strongest immune response to the causative agent of urogenital chlamydia, in particular a.r. of this site forms the species-specific and serovar-specific epitopes [21] [22] [23] [24] [25] .
After three rounds of affinity selection from the non-amplified elutes of the last round 11 phage clones (McAb 293F4), 10 phage clones (McAb 291F8) and 12 phage clones (McAb 296G2) were identified (and the sequence of insertions was determined) (Fig. 2) . Alignment of the obtained peptides from MOMP C. trachomatis allowed locating the specified a.r.
Consequently, the epitope that interacts with McAb 293F4 is localized on a site 320-325 a.r. in the form of "TTLNPT" sequence. It is also worth noting the significance of a.r. at 323 rd place: in almost all clones there is an amino acid residue of asparagine N (Asn) at this site, but in several clones in this position there is glutamine D (Asp). Asparagine and aspartic acid have approximately the same size of the side radical, although somewhat differ in charge of the radical. Consequently, this position is also important for binding of the antibody. Thus, this antigenic determinant forms by 4 polar a.r. (T, N) and 2 nonpolar a.r. (P, L). The sequence (320)TTLNPT(325) is part of L7 loop (in native form it is located above the transmembrane space of the microorganism).
The antigenic determinant that binds to McAb 291F8 is localized at the site 326-330 a.r. in the form of "VLDVT" sequence. Amino acid residues that form this epitope, also refer to both polar (D, T) and nonpolar (V, L). This sequence is also part of L7 loop.
The epitope that interacts with the paratope of McAb 296G2 is localized on the site 347-352 a.r. in the form of "IVSLQL" sequence. Note that a.r. 
